Ranbaxy gets US approval to launch Absorica

360° SearchNetwork Hot Spots Trends Time Series

Published May 30 2012 by Topnews.in

Ranbaxy gets US approval to launch Absorica

Indian pharmaceutical major, Ranbaxy Laboratories has said that it has received approval from the U. S. Food and Drug Administration to launch Absorica in the country.

The patented acne treatment drug, Absorica has been developed by Canadian firm Cipher Pharmaceuticals. Ranbaxy announced that it will is planning...

READ FULL ARTICLE

Share this

Editorial: Inflation prescription

in pharma, cap price hikes in wheat/rice etcPolicymakers in India, especially in the finance ministry, have spent over a year battling RBI on inflation control when the solution was staring them in the face: put annual caps on price hikes that will be ... [Published Financial Express - 2 hours ago]

Entities: Inflation, Drugs, Kotak Mahindra Group, Sun Pharmaceutical Industries Ltd

First reported 8 hours ago - Updated 8 hours ago - 1 reports

Why did drug firm ignore warnings?

It’s a sad commentary on the integrity of a company like Ranbaxy, one of India’s top pharmaceutical firms, that its American arm was compelled to plead guilty to distributing adulterated drugs made in India in the United States in 2005-06.What is inexplicable ... [Published Deccan Chronicle - 8 hours ago]

Entities: Ranbaxy Laboratories Ltd, Drugs, India, Paonta Sahib (India)

First reported 10 hours ago - Updated 10 hours ago - 1 reports

FDA Food & Drug Administration

WHEN I WAS IN LAW PRACTICE, WE HAD A CASE INVOLVING THIS PROBLEM: Those Generic Drugs May Not Have …

WHEN I WAS IN LAW PRACTICE, WE HAD A CASE INVOLVING THIS PROBLEM: Those Generic Drugs May Not Have Been What You Thought They Were: Years of abuses at Ranbaxy raise worries about the FDA’s oversight of the generics market. This is the week for arguments ... [Published Instapundit - 10 hours ago]

Entities: Ranbaxy Laboratories Ltd, Drugs, FDA Food & Drug Administration, Complaints, Cipla Ltd

First reported May 18 2013 - Updated May 18 2013 - 3 reports

Pharmaceutical manufacturer in India to pay Ohio $3.8 million

(Norwalk Reflector - McClatchy-Tribune Information Services via COMTEX) --Ohio Attorney General Mike DeWine announced that Ohio has joined with other states and the federal government in a $500 million dollar settlement to resolve civil and criminal allegations ... [Published TradingCharts.com - May 18 2013]

Entities: Ranbaxy Laboratories Ltd, India, Medicaid

First reported May 18 2013 - Updated May 18 2013 - 2 reports

Fendt

7 stories to read this weekend

What a week! Google I/O 2013 kept us busy and then last night it was Yahoo and Tumblr trying to get it on. I am just surprised I even had time to breathe, forget reading. But somehow I managed and here are seven gems I can recommend for your reading ... [Published GigaOM - May 18 2013]

Entities: James Meek, Fendt, Phil Jackson, Ranbaxy Laboratories Ltd

First reported May 18 2013 - Updated May 18 2013 - 1 reports

GlaxoSmithKline plc

Glaxo hit the most by drug price control order

Pharma firms stare at setbacks in the new regime.Consumers may celebrate the new drug price control order (DPCO), which was unveiled Thursday, as it promises to lower drug prices up to 80%. But pharmaceutical companies are staring at potential setbacks ... [Published DNA India - May 18 2013]

Entities: GlaxoSmithKline plc, Price Control, Satish Reddy, Drugs

First reported May 18 2013 - Updated May 18 2013 - 1 reports

Ranbaxy Laboratories Ltd

Ranbaxy and Justice Settle Manufacturing Compliancy Case

Generic drugmaker Ranbaxy announced May 13 it has agreed to a $500 million settlement with the Department of Justice following allegations of poor data integrity and manufacturing practices at three of its Indian facilities and a facility in Upstate New ... [Published FDA News - May 18 2013]

Entities: Ranbaxy Laboratories Ltd, Manufacturing, Data Integrity

Blogs

sort by: Date \| Relevance
WHEN I WAS IN LAW PRACTICE, WE HAD A CASE INVOL... [Published Instapundit - 10 hours ago] WHEN I WAS IN LAW PRACTICE, WE HAD A CASE INVOLVING THIS PROBLEM: Those Generic Drugs May Not Have Been What You Thought They Were: Years of abuses at Ranbaxy raise worries about the FDA’s oversight of the generics market. This is the week for arguments ...
10 Weekend Reads [Published The Big Picture Blog - May 18 2013] My longer form weekend reading material: • How the Case for Austerity Has Crumbled ( NYRB ) • The changing nature of work: Increasing automation is fundamentally shifting the nature of work away from ‘making stuff’ towards personal services. ( piera ...
7 stories to read this weekend [Published GigaOM - May 18 2013] What a week! Google I/O 2013 kept us busy and then last night it was Yahoo and Tumblr trying to get it on. I am just surprised I even had time to breathe, forget reading. But somehow I managed and here are seven gems I can recommend for your reading ...
7 stories to read this weekend [GigaOM] [Published GigaOM Network - May 18 2013] What a week! Google I/O 2013 kept us busy and then last night it was Yahoo and Tumblr trying to get it on. I am just surprised I even had time to breathe, forget reading. But somehow I managed and here are seven gems I can recommend for your reading ...
A Little Ranbaxy Example [Published In the Pipeline - May 17 2013] Compare and contrast. Here we have Krishnan Ramalingam, from Ranbaxy's Corporate Communications department, in 2006 : Being a global pharmaceutical major, Ranbaxy took a deliberate decision to pool its resources to fight neglected disease segments. ...

Audio/Video

sort by: Date \| Relevance
Ranbaxy Halts Production of Generic Lipitor: Ho... [Published TheStreet.com - YouTube - Nov 30 2012]

Press Releases

sort by: Date \| Relevance
Just Released: "Lohmann & Rauscher GmbH & Co. K... [Published PR inside - 20 hours ago]
Fortson Dermatology & Skin Care Center to Host ... [Published PR Newswire: Consumer Products & Retail - May 17 2013]
Dr. Monib Zirvi, Dermatology, is named a Top Do... [Published PR Newswire: General Business - May 15 2013]
Research and Markets: Psoriasis Partnering 2007... [Published Business Wire Health News - May 14 2013]
India's Largest Generic Drugmaker Ranbaxy Pays ... [Published PR Newswire - May 13 2013]